Risk factors and distinguishing features of cancer in IBD

Inflammatory Bowel Diseases

Volumn 4, Issue 3, 1998, Pages 235-243

  Ekbom, Anders ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENTERITIS; EPIDEMIOLOGY; HEALTH SURVEY; HUMAN; INCIDENCE; METHODOLOGY; MORBIDITY; NEOPLASM; REVIEW; RISK FACTOR;

BIAS (EPIDEMIOLOGY); CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MORBIDITY; NEOPLASMS; POPULATION SURVEILLANCE; RESEARCH DESIGN; RISK FACTORS;

EID: 0032135695     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199808000-00007     Document Type: Review

References (86)

1. Crohn BB, Rosenberg M. Sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci 1925;170:220.
2. Bargen JA. Chronic ulcerative colitis associated with malignant disease. Arch Surg 1928;17:561-76.
3. Ekbora A, Helmick C, Zack M, Adami HO. Extracolonic malignancies in inflammatory bowel disease. Cancer 1991;67:2015-19.
4. Persson PG, Karlen P, Bernell O, Leijonmarck CE, Brostrom O, Ahlbom A, Hellers G. Crohn's disease and cancer: a population-based cohort study. Gastroenterology 1994;107:1675.
5. Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992;103: 954-60.
6. Fielding JF, Prior P, Waterhouse JA, Cooke WT. Malignancy in Crohn's disease. Scand J Gastroenterol 1972;7:3-7.
7. Greenstein J, Gennuso R, Sachar DB, Heimann T, Smith H, Janowitz HD, Aufses AH Jr. Extraintestinal cancers in inflammatory bowel disease. Cancer 1985;56:2914-21.
8. Mir-Madjlessi SH, Farmer RG, Easly KA, Beck GJ. Colorectal cancer and extra-colonic malignancies in ulcerative colitis. Cancer 1986;58:1569-74.
9. Prior P, Gyde SN, Macartney JC, Thompson H, Waterhouse JAH, Allan RN. Cancer morbidity in ulcerative colitis. Gut 1982;23: 490-7.
10. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JAH, Allan RN. Malignancy in Crohn's disease. Gut 1980;21:1024-9.
11. Boller R. Erfahrungen an 89 Colitis-ulcerosa-Fällen der Abteilung Boller im Allgemeinen Krankenhaus Wien [in German]. Gastroenterologia 1956;86:693-6.
12. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulceralive colitis. Br Med J 1982;284:706.
13. Lindberg E, Tysk C, Andersson K, Järnerot G. Smoking and inflammatory bowel disease. A case control study. Gut 1988;29: 352-7.
14. Benoni C, Nilsson Å. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1987;125:445-52.
15. Sandler RS, Wurzelman JL, Lyles CM. Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology 1992;3: 374-8.
16. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease (IBD) - a population-based cohort study. Am J Gyn Obstet 1997;177:942-6.
17. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni JF Jr. Incidence of cancer among patients with rheumatoid arthritis. JNCI 1993;85:307-11.
18. Cohn EM, Pearlstine B. Inflammatory bowel disease and leukemia. J Clin Gastroenterol 1984;6:33-5.
19. Cuttner J. Increased incidence of acute promyelocytic leukemia in patients with ulcerative colitis. Ann Intern Med 1982;97:864-5.
20. Gutknecht J, Humbert P, Dupond JL, Mallet H. Leukemia and Crohn's disease. Dig Dis Sci 1986;31:1391.
21. Newell GR, Mills PK, Johnson DE. Epidemiologic comparison of cancer of the testis and Hodgkins's disease among young males. Cancer 1994;54:1117-23.
22. Greenstein AJ, Mullin GE, Strauchen JA, Heiman T, Janowitz HD, Aufses AH Jr, Sachar DB. Lymphoma in inflammatory bowel disease. Cancer 1992;69:1119-23.
23. Baecklund E, Ekbom A, Sparén P, Feltelius N, Klareskog L. Disease activity determines lymphoma risk in patients with rheumatoid arthritis. A nested case-control study. Br J Med (in press).
24. Larvol L, Soule JC, Le Toumeau A. Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease [Correspondence]. N Engl J Med 1994;331:883-4.
25. Olsson R, Danielsson Å, Järnerot G, Lindström E, Lööf L, Rolny P, Rydén BO, Tysk C, Wallerstedt S. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100:1319-23.
26. Broomé U, Olsson R, Lööf L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Bertzén H, Wallerstedt S, Lindberg G. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610-15.
27. Choi PM, Nugent FW, Zelig MP, Munson JL, Schoetz DJ. Cholangiocarcinoma and Crohn's disease. Dig Dis Sci 1994;39:667-70.
28. Kornfeld D, Ekbom A, Ihre T. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis - a population-based study. Scand J Gastroenterol 1997;32:1042-5.
29. Senay E, Sachar DB, Keohane M, Greenstein AJ. Small bowel carcinoma in Crohn's disease. Distinguishing features and risk factors. Cancer 1989;63:360-3.
30. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981;48:2742-5.
31. Munkholm P, Langholz E, Davidson M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993;105:1716-23.
32. Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev 1994;3:205-7.
33. Fireman Z, Grossman A, Lilos P, Hacohen D, Bar Meir S, Rozen P, Gilat T. Intestinal cancer in patients with Crohn's disease. A population study in central Israel. Scand J Gastroenterol 1989;24: 346-50.
34. Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF. Crohn's disease and cancer. N Engl J Med 1973;289:1099-1102.
35. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JAH, Allan RN. Malignancy in Crohn's disease. Gut 1980;21:1024-9.
36. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-9.
37. Gillen CD, Andrews HA, Prior P, Allan RN. Crohn's disease and colorectal cancer. Gut 1994;35:651-5.
38. Rubio CA, Befrits R. Colorectal adenocarcinoma in Crohn's disease. Dis Colon Rectum 1997;40:1072-8.
39. Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Lennard-Jones JE. Lower gastrointestinal malignancy in Crohn's disease. Gut 1994;35:347-52.
40. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994;25:1590-2.
41. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994;35:950-4.
42. Devroede GJ, Taylor WF, Saucer WG, Jackman RJ, Stickler GB. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;285:17-21.
43. Bonnevie O, Binder V, Anthonisen P, Riis P. The prognosis of ulcerative colitis. Scand J Gastroenterol 1974;9:81-91.
44. Broström O, Löfberg R, Nordenvall B, Öst Å. Hellers G. The risk of colorectal cancer in ulcerative colitis: an epidemiologic study. Scand J Gastroenterol 1987;22:1193-9.
45. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. IV. Carcinoma of the colon. Gut 1964;5:15-22.
46. Gilat T, Fireman Z, Grossman A, Hacohen D, Kadish U, Ron E, Rozen P, Lilos P. Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology 1988;94:870-77.
47. Greenstein A, Sachar D, Smith H, Pucillo A, Papatestas AE, Kreel I, Geller SA, Janowitz HD, Aufses AH Jr. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979;77:290-4.
48. Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, Lofberg R, Brostrom O, Hellers G. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29:206-17.
49. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis - based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:158-63.
50. Katzka I, Brody R, Morris E, Katz S. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology 1983;85:22-9.
51. Kewenter J, Ahlman H, Hulten L. Cancer risk in extensive ulcerative colitis. Ann Surg 198;188:824-8.
52. Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB. Cancer surveillance in ulcerative colitis: experience over 15 years. Lancet 1983;ii:149-52.
53. Maratka Z, Nedbal J, Kocianova J, Havelka J, Kudrmann J, Hendl J. Incidence of colorectal cancer in proctocolitis: a retrospective study of 959 cases over 40 years. Gut 1985;26:43-9.
54. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer; a population-based study. N Engl J Med 1990; 323:1228-33.
55. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.
56. Mellemkjaer L, Olsen JH, Frisch M, Johansen C, Gridley G, McLaughlin JK. Cancer in patients with ulcerative colitis. Int J Cancer 1995;60:330-3.
57. Stewenius J, Adnerhill I, Andersen H, Ekelund GR, Floren CH, Fork FT, Janzon L, Lindstrom C, Ogren M. Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmö, Sweden. Int J Colorectal Dis 1995;10:117-22
58. Rhodes JM. Unifying hypothesis for inflammatory bowel disease and associated colon cancer: sticking the pieces together with sugar. Lancet 1996;347:40-4.
59. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Part I. Short-term prognosis. Gut 1963;4:299-308.
60. Sugita A, Sachar DB, Bodian C, Ribeiro MB, Aufses AH Jr, Greenstein AJ. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 1991;32:167-9.
61. Broomé U, Lindberg G, Löfberg R. Primary sclerosing cholangitis in ulcerative colitis: a risk factor for the development of dysplasia and DNA-aneuploidy? Gastroenterology 1992;102:1877-80.
62. D'Haens GR, Lashner BA, Hanauer SB. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 1993;88:1174-8.
63. Loftus EV Jr., Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton III LJ. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996;110:432-40.
64. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996;110:331-8.
65. Odes HS, Fraser D. Ulcerative colitis in Israel: Epidemiology, morbidity and genetics. Public Health Rev 1989-1990;17:297-319.
66. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant with primary sclerosing cholangitis? A population based study. Gut 1997;41:522-5.
67. Lynch DAF, Lobo AJ, Sobala GM, Dixon MF, Axon ATR. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34: 1075-80.
68. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer among patients with ulcerative colitis - a case-control study. Gastroenterology 1994;107:117-20.
69. Moody GA, Jayanthi V, Probert CS, Mac Kay H, Mayberry JF. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 1996;8:1179-83.
70. Lashner BA, Heidenreich PA, Su GL, Kance SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology 1989;97: 255-9.
71. Thun M, Namboodiri N, Heath CJ. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
72. Giovanucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995;87:265-73.
73. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, Speizer FE, Willett WC. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993;85:875-84.
74. Lashner BA, Heidenreich PA, Su GL, Kance SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology 1989;97: 255-9.
75. Lashner BA, Provencher KS, Seidner DL, Knesebeck A, Brzezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 1997; 112:29-32.
76. Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large population-based study in Sweden. Gastroenterology 1991;100:350-8.
77. Lashner BA, Provencher KS, Bozdech JM, Brzezinski A. Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. Am J Gastroenterol 1995;90:377-80.
78. Karlén P, Kornfeld D, Broström O, Löfberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population-based case-control study. Gut 1998;42:711-14.
79. Lynch DAF, Lobo AJ, Sobala GM, Dixon MF, Axon ATR. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34: 1075-80.
80. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-4.
81. Choi PM, Nugent FW, Schoetz DJ, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105: 418-24.
82. Löfberg R, Broström B, Karlén P, Tribukait B, Öst Å. Colonoscopic surveillance in long-standing total ulcerative colitis - a 15-year follow-up study. Gastroenterology 1990;99:1021-31.
83. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
84. Zack MM, Ekbom A, Persson PG, Adami HO. Evaluation of surveillance programs for colorectal cancer in ulcerative colitis patients by case-control studies: Methodological considerations. J Med Screen 1997;4:137-11.
85. Sachar D. Cancer in Crohn's disease: dispelling the myth. Gut 1994;35:1507-8.
86. Yamazaki Y, Riberiro MB, Sachar DB, Aufses AH Jr, Greenstein AJ. Malignant strictures in Crohn's disease. Am J Gastroenterol 1991;86:882-5.